Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Common stock, Par value $ 0.0001 $ 0.0001
Common stock, Shares authorized 100,000,000 100,000,000
Common stock, Shares issued 20,495,979 19,858,127
Common stock, Shares outstanding 20,495,979 19,858,127
Accounts receivable, net of allowance for expected credit losses $ 461 $ 360